ESTRO 2024 - Abstract Book

S1896

Clinical - Mixed sites, palliation

ESTRO 2024

Conclusion:

The maximum tolerable dose has been reached in any study arm with a good toxicity profile and promising LC rates

Keywords: Radiosurgery, Phase I study, VMAT

References:

1. Deodato F, Cilla S, Macchia G, Torre G, Caravatta L, Mariano G, Mignogna S, Ferro M, Mattiucci GC, Balducci M, Frascino V, Piermattei A, Ferrandina G, Valentini V, Morganti AG. Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2). Clin Oncol (R Coll Radiol). 2014 Dec;26(12):748-56. doi: 10.1016/j.clon.2014.08.005. Epub 2014 Aug 29. PMID: 25175042.

1113

Digital Poster